• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用转移淋巴结比率评估根治性食管癌手术后淋巴结转移患者的预后。

Use of the metastatic lymph node ratio to evaluate the prognosis of esophageal cancer patients with node metastasis following radical esophagectomy.

机构信息

State Key Laboratory of Oncology in Southern China, Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China ; Guangdong Esophageal Cancer Research Institute, Guangzhou, Guangdong, People's Republic of China.

出版信息

PLoS One. 2013 Sep 9;8(9):e73446. doi: 10.1371/journal.pone.0073446. eCollection 2013.

DOI:10.1371/journal.pone.0073446
PMID:24039944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3767826/
Abstract

OBJECTIVES

The objective of this study was to investigate the number of metastatic lymph nodes (pN) and the metastatic lymph node ratio (MLR) on the post-surgical prognosis of Chinese patients with esophageal cancer (EC) and lymph node metastasis.

METHODS

We enrolled 353 patients who received primary curative resection for EC from 1990 to 2003. The association of pN and MLR with 5-year overall survival (OS) was examined by receiver operating characteristic (ROC) and area under the curve (AUC) analysis. The Kaplan-Meier method was used to calculate survival rates, and survival curves were compared with the log-rank test. The Cox model was employed for univariate and multivariate analyses of factors associated with 5-year OS.

RESULTS

The median follow-up time was 41 months, and the 1-, 3- and 5-year OS rates were 71.2%, 30.4%, and 19.5%, respectively. Univariate analysis showed that age, pN stage, and the MLR were prognostic factors for OS. Patients with MLRs less than 0.15, MLRs of 0.15-0.30, and MLRs greater than 0.30 had 5-year OS rates of 30.1%, 17.8%, and 9.5%, respectively (p < 0.001). Patients classified as pN1, pN2, and pN3 had 5-year OS rates of 23.7%, 11.4%, and 9.9%, respectively (p < 0.001). Multivariate analysis indicated that a high MLR and advanced age were significant and independent risk factors for poor OS. Patients classified as pN2 had significantly worse OS than those classified as pN1 (p = 0.022), but those classified as pN3 had similar OS as those classified as pN1 (p = 0.166). ROC analysis indicated that MLR (AUC = 0.585, p = 0.016) had better predictive value than pN (AUC = 0.565, p = 0.068).

CONCLUSIONS

The integrated use of MLR and pN may be suitable for evaluation of OS in Chinese patients with EC and positive nodal metastasis after curative resection.

摘要

目的

本研究旨在探讨中国食管癌(EC)伴淋巴结转移患者术后淋巴结转移(pN)数量和淋巴结转移率(MLR)与预后的关系。

方法

纳入 1990 年至 2003 年间接受根治性切除术的 353 例 EC 患者。采用受试者工作特征(ROC)曲线和曲线下面积(AUC)分析 pN 和 MLR 与 5 年总生存率(OS)的关系。采用 Kaplan-Meier 法计算生存率,并用对数秩检验比较生存曲线。采用 Cox 模型进行单因素和多因素分析,评估与 5 年 OS 相关的因素。

结果

中位随访时间为 41 个月,1、3 和 5 年 OS 率分别为 71.2%、30.4%和 19.5%。单因素分析显示,年龄、pN 分期和 MLR 是 OS 的预后因素。MLR<0.15、0.15-0.30 和>0.30 的患者 5 年 OS 率分别为 30.1%、17.8%和 9.5%(p<0.001)。pN1、pN2 和 pN3 患者的 5 年 OS 率分别为 23.7%、11.4%和 9.9%(p<0.001)。多因素分析表明,高 MLR 和高龄是 OS 不良的显著独立危险因素。pN2 患者的 OS 明显差于 pN1 患者(p=0.022),但 pN3 患者的 OS 与 pN1 患者相似(p=0.166)。ROC 分析表明,MLR(AUC=0.585,p=0.016)比 pN(AUC=0.565,p=0.068)具有更好的预测价值。

结论

在根治性切除术后,MLR 和 pN 的综合应用可能适合评估中国 EC 伴阳性淋巴结转移患者的 OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/f972baabfaa5/pone.0073446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/3da9a8b9c036/pone.0073446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/be0bedb3d3b1/pone.0073446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/f972baabfaa5/pone.0073446.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/3da9a8b9c036/pone.0073446.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/be0bedb3d3b1/pone.0073446.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a34e/3767826/f972baabfaa5/pone.0073446.g003.jpg

相似文献

1
Use of the metastatic lymph node ratio to evaluate the prognosis of esophageal cancer patients with node metastasis following radical esophagectomy.使用转移淋巴结比率评估根治性食管癌手术后淋巴结转移患者的预后。
PLoS One. 2013 Sep 9;8(9):e73446. doi: 10.1371/journal.pone.0073446. eCollection 2013.
2
[Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].[根治性切除术后食管胃交界腺癌患者转移淋巴结数量及转移淋巴结比率对预后的影响]
Zhonghua Zhong Liu Za Zhi. 2014 Feb;36(2):141-6.
3
[Relationship between metastatic lymph node and prognosis of esophageal cancer patients treated with following radical esophagectomy].[食管癌患者根治性食管切除术后转移淋巴结与预后的关系]
Zhonghua Yi Xue Za Zhi. 2016 Dec 20;96(47):3829-3832. doi: 10.3760/cma.j.issn.0376-2491.2016.47.013.
4
Prognostic significance of number of lymph node metastasis on survival in patients with pathological T3 esophageal carcinoma.病理 T3 食管癌患者淋巴结转移数对生存的预后意义。
Neoplasma. 2017;64(1):131-135. doi: 10.4149/neo_2017_116.
5
[Prognostic value of three different staging schemes based on pN, MLR and LODDS in patients with T3 esophageal cancer].[基于pN、MLR和LODDS的三种不同分期方案对T3期食管癌患者的预后价值]
Zhonghua Zhong Liu Za Zhi. 2017 Oct 23;39(10):749-753. doi: 10.3760/cma.j.issn.0253-3766.2017.10.006.
6
Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.在根治性食管切除术和三野淋巴结清扫术后,颈淋巴结转移在胸段食管鳞状细胞癌中被归类为区域淋巴结分期。
BMC Surg. 2014 Dec 19;14:110. doi: 10.1186/1471-2482-14-110.
7
[Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].[阳性淋巴结对数比对于胸段食管鳞癌根治性食管切除术后淋巴结阴性患者预后的预测价值]
Zhonghua Wei Chang Wai Ke Za Zhi. 2016 May;19(5):535-9.
8
Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan.食管癌分期中转移性淋巴结数量临界值的验证:日本655例患者的多机构分析
Esophagus. 2024 Oct;21(4):464-471. doi: 10.1007/s10388-024-01084-6. Epub 2024 Aug 24.
9
Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes.使用阳性淋巴结的对数优势比评估食管鳞状细胞癌患者食管切除术后的预后。
Oncotarget. 2015 Nov 3;6(34):36911-22. doi: 10.18632/oncotarget.5366.
10
Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.淋巴结比率作为转移性淋巴结数量的替代指标用于预测食管癌患者的生存率
Dig Dis Sci. 2015 Sep;60(9):2771-6. doi: 10.1007/s10620-015-3681-1. Epub 2015 May 5.

引用本文的文献

1
Impact of Dissected Lymph Node Count and Positive Lymph Node Ratio Following Esophagectomy on Long-Term Outcomes in Esophageal Cancer: A Systematic Review and Meta-Analysis.食管癌切除术后清扫淋巴结数量及阳性淋巴结比例对长期预后的影响:一项系统评价和Meta分析
Ann Surg Open. 2025 Jun 13;6(2):e587. doi: 10.1097/AS9.0000000000000587. eCollection 2025 Jun.
2
Association of metformin use with risk and survival outcome of esophageal cancer in patients with diabetes: A systematic review and meta-analysis.二甲双胍使用与糖尿病患者食管癌风险及生存结局的关联:一项系统评价与荟萃分析
PLoS One. 2025 Jan 7;20(1):e0310687. doi: 10.1371/journal.pone.0310687. eCollection 2025.
3

本文引用的文献

1
Modification of nodal categories in the seventh american joint committee on cancer staging system for esophageal squamous cell carcinoma in Chinese patients.中国患者食管鳞癌第七版美国癌症联合委员会分期系统中淋巴结分类的修订。
Ann Thorac Surg. 2011 Jul;92(1):216-24. doi: 10.1016/j.athoracsur.2011.03.032.
2
Treatment guideline of radiotherapy for Chinese esophageal carcinoma (draft).中国食管癌放射治疗指南(草案)
Chin J Cancer. 2010 Oct;29(10):855-9.
3
Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma.
Lymph node ratio is a prognostic indicator for locally advanced gastric cancer after neoadjuvant immunochemotherapy.
淋巴结比率是新辅助免疫化疗后局部进展期胃癌的预后指标。
BMC Gastroenterol. 2024 Oct 19;24(1):371. doi: 10.1186/s12876-024-03462-x.
4
Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.淋巴结比率是新辅助免疫化疗后局部晚期食管鳞癌的预后指标。
Biomol Biomed. 2024 Jan 3;24(1):159-169. doi: 10.17305/bb.2023.9435.
5
Development and validation of the novel subclassification of pN3 for patients with esophageal cancer.食管癌患者pN3新亚分类的开发与验证
Front Oncol. 2023 May 2;13:1113711. doi: 10.3389/fonc.2023.1113711. eCollection 2023.
6
A prognostic nomogram based on lymph node ratio for postoperative vulvar squamous cell carcinoma from the Surveillance, Epidemiology, and End Results database: a retrospective cohort study.一项基于监测、流行病学和最终结果数据库中淋巴结比值的术后外阴鳞状细胞癌预后列线图:一项回顾性队列研究。
Ann Transl Med. 2020 Nov;8(21):1382. doi: 10.21037/atm-20-3240.
7
Modified nodal stage of esophageal cancer based on the evaluation of the hazard rate of the negative and positive lymph node.基于阴性和阳性淋巴结危险率评估的食管癌改良淋巴结分期。
BMC Cancer. 2020 Dec 7;20(1):1200. doi: 10.1186/s12885-020-07664-w.
8
Comparison of three lymph node staging systems in evaluating the prognosis of patients with pT3 esophageal squamous cell carcinoma.三种淋巴结分期系统在评估 pT3 期食管鳞癌患者预后中的比较。
Sci Rep. 2020 Oct 13;10(1):17161. doi: 10.1038/s41598-020-74327-y.
9
Prognostic value of the number of lymph nodes resected in patients with lymph-node-negative esophageal squamous cell carcinoma.淋巴结阴性食管鳞状细胞癌患者切除淋巴结数量的预后价值
Int J Clin Exp Pathol. 2020 Mar 1;13(3):597-606. eCollection 2020.
10
Log odds of positive lymph nodes is a novel prognostic indicator for advanced ESCC after surgical resection.阳性淋巴结的对数比值是手术切除后晚期食管鳞癌的一种新型预后指标。
J Thorac Dis. 2017 May;9(5):1182-1189. doi: 10.21037/jtd.2017.03.187.
转移淋巴结与切除淋巴结总数的比值是食管癌生存的预后因素。
J Thorac Oncol. 2010 Sep;5(9):1467-71. doi: 10.1097/jto.0b013e3181e8f6b1.
4
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.《美国癌症联合委员会(AJCC)癌症分期手册》第7版:食管和食管胃交界部
Ann Surg Oncol. 2010 Jul;17(7):1721-4. doi: 10.1245/s10434-010-1024-1.
5
Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.比较第 6 版和第 7 版美国癌症联合委员会肿瘤-淋巴结-转移分期系统在食管癌切除患者中的应用。
Ann Thorac Surg. 2010 Apr;89(4):1024-31. doi: 10.1016/j.athoracsur.2010.01.017.
6
An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.评估淋巴结检查数量和淋巴结阴性食管癌的生存情况:来自中国的数据。
Ann Surg Oncol. 2010 Jul;17(7):1901-11. doi: 10.1245/s10434-010-0948-9. Epub 2010 Feb 10.
7
Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.淋巴结转移和淋巴结比率在食管鳞癌中的预后价值。
Eur J Surg Oncol. 2010 Feb;36(2):155-9. doi: 10.1016/j.ejso.2009.09.005. Epub 2009 Oct 25.
8
The metastatic lymph node number and ratio are independent prognostic factors in esophageal cancer.转移淋巴结数目和比例是食管癌的独立预后因素。
J Gastrointest Surg. 2009 Nov;13(11):1913-20. doi: 10.1007/s11605-009-0982-8. Epub 2009 Aug 12.
9
Esophageal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.食管癌:ESMO关于诊断、治疗及随访的临床建议
Ann Oncol. 2009 May;20 Suppl 4:32-3. doi: 10.1093/annonc/mdp121.
10
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.切除的淋巴结数量可预测食管癌患者的生存率:一项关于手术切除范围影响的国际研究。
Ann Surg. 2008 Oct;248(4):549-56. doi: 10.1097/SLA.0b013e318188c474.